TITLE

CHEMQ RESEARCH TARGETS GLOBAL HUMAN PHARMACEUTICAL MARKETS

PUB. DATE
January 2003
SOURCE
Worldwide Biotech;Jan2003, Vol. 15 Issue 1, p1
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports on the research started by pharmaceutical company Chemeq Ltd. which is aimed at taking the company into global human pharmaceutical markets.
ACCESSION #
8775072

 

Related Articles

  • CHEMEQ DEVELOPS POLYMER-BASED SUNSCREEN AND SKIN EMOLLIENT.  // Worldwide Biotech;Mar2003, Vol. 15 Issue 3, p6 

    Deals with the sunscreen and skin emollient developed by Chemeq Ltd., a pharmaceutical company.

  • Falling down a well. Haselhurst, David; Peter, Freeman // Bulletin with Newsweek;03/13/2001, Vol. 119 Issue 6265, p65 

    Reports the valuation of several corporate stocks in Australia. Details on the Puffin 6 well project of Norwest Energy; Impact on the value of Norwest shares; Information on the Chemeq portfolio. INSET: BLUE CHIP..

  • Gut feeling. Haselhurst, David // Bulletin with Newsweek;2/5/2002, Vol. 120 Issue 6310, p53 

    Examines the market performance of Australia-based biotechnology firm Chemeq as of February 5, 2002. Stock prices; Range of product offerings; Other growth targets and strategies.

  • A future in pork bellies. Haselhurst, David // Bulletin with Newsweek;03/07/2000, Vol. 118 Issue 6214, p71 

    Focuses on the decline of the share price of Chemeq. Successful results from three preliminary pig-feeding trials; Development of the germicide Chemyde; Emphasis on perfecting formulations for different applications; Identification of three world markets.

  • Hot tip. Haselhurst, David // Bulletin with Newsweek;10/23/2001, Vol. 119 Issue 6298, p87 

    Presents news concerning Australian companies' stock performance as of October 23, 2001. Reasons for copper drilling company Oxiana Resources' stocks to be valued at less than their worth; Price of video conferencing company Zylotech's stocks as of October 6; Rise in the stock price of...

  • CHEMEQ ON THE NOSE. Quinlivan, Beth // BRW;9/30/2004, Vol. 26 Issue 38, p23 

    Reports on the financial performance of Chemeq Ltd., developer of animal pharmaceutical product in Australia. Budget imbalance in the cost of building the manufacturing plant; Competition with Imugene and Biodiem in the biotechnology sector; Decline in the price of corporate stocks.

  • BIO'S FLU WORSENS. Quinlivan, Beth // BRW;6/2/2005, Vol. 27 Issue 21, p18 

    Reports on the trading performance of biotechnology stocks in Australia. Problems in commissioning the new pharmaceutical manufacturing plant of Chemeq Ltd.; Release of ambiguous clinical trials results of the anti-obesity drug developer, Metabolic Pharmaceuticals; Decline in the market value of...

  • Chemeq rescue.  // BRW;1/13/2005, Vol. 27 Issue 1, p80 

    Reports on biotechnology company, Chemeq's deal with a division of Japanese bank, Mizuho Financial Group, which involves the latter's investment in return for Chemeq's stock and the rights to install its own management team.

  • Wall Street cracks. Nicholson, Colin // BRW;8/12/2004, Vol. 26 Issue 31, p76 

    Focuses on the performance of the stock market in Australia. Move of investors to continue to hold uptrending stocks; Recovery of the stocks of Symex Holdings Ltd.; Increase in the stock price of Chemeq.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics